TLX250-CDx is an investigational PET 3 drug product for the non-invasive diagnosis and characterization of clear cell renal cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer ...

This NDA submission marks a pivotal moment for Chimerix in our mission to bring this potentially life-altering drug to patients diagnosed with recurrent H3 K27M-mutant diffuse glioma,” said Mike ...

This achievement marks SuperCom's first entry into South Dakota, further strengthening its presence in the United States.

Here's a month-by-month look back at this year's biggest events that affected agriculture in Pennsylvania and surrounding ...

Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has submitted its Biologics ...

Two major policies that could impact Indigenous nations are President-elect Donald Trump’s push to increase oil and gas ...

A man with 11 kids who spends Christmas Eve tweeting, Elon Musk — the ketamine-fueled Bond villain and richest human in world ...

Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN), a developer of AI-powered autonomous driving software solutions for ...

We do not offer financial advice, advisory or brokerage services, nor do we recommend or advise individuals or to buy or sell particular stocks or securities. Performance information may have ...

We do not offer financial advice, advisory or brokerage services, nor do we recommend or advise individuals or to buy or sell particular stocks or securities. Performance information may have ...

The Sentencing Commission hereby gives notice of an amendment to the policy statement and commentary in the Guidelines Manual that provides for a reduction in a defendant's term of imprisonment as a ...